Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoromethanesulfonic Acid SCHEMBL5274319 | 1.00 | GPR3 (0.35) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL31258263 | 0.95 | GPR3 (0.35) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL15821415 | 0.95 | GPR3 (0.35) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL9690187 | 0.87 | GPR3 (0.32) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL10889679 | 0.81 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL25292546 | 0.76 | GPR3 (0.48) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL5743813 | 0.76 | — | — | |
| Trifluoromethanesulfonic Acid SCHEMBL29253571 | 0.72 | GPR3 (0.39) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL9109080 | 0.72 | GPR3 (0.39) | GPR3 | |
| Trifluoromethanesulfonic Acid SCHEMBL663144 | 0.72 | GPR3 (0.39) | GPR3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240391878-A1 | METHOD FOR PREPARING TERT-BUTYL (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-1-CARBOXYLATE AND SALTS THEREOF AND ITS USE IN A METHOD FOR PREPARING (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE AND SALTS THEREOF | MOEHS IBERICA, S.L. (ES) | 2024-11-28 | — | — | US | disclosed |
| EP-4467534-A1 | METHOD FOR PREPARING TERT-BUTYL (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-1-CARBOXYLATE AND SALTS THEREOF AND ITS USE IN A METHOD FOR PREPARING (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE AND SALTS THEREOF | Moehs Ibérica, S.L. (ES) | 2024-11-27 | — | — | EP | disclosed |
| US-12012426-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2024-06-18 | — | — | US | disclosed |
| US-20230219983-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-07-13 | — | — | US | disclosed |
| US-11639362-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | TAKASAGO INTERNATIONAL CORPORATION (JP) | 2023-05-02 | — | — | US | disclosed |
| EP-3750896-B1 | CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND | TAKASAGO PERFUMERY CO LTD (JP) | 2022-06-29 | — | — | EP | disclosed |
| EP-3848378-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | Takasago International Corporation (JP) | 2021-07-14 | — | — | EP | disclosed |
| EP-3438113-B1 | TETRADENTATE LIGAND, AND PRODUCTION METHOD THEREFOR, SYNTHETIC INTERMEDIATE THEREOF, AND TRANSITION METAL COMPLEX THEREOF | TAKASAGO PERFUMERY CO LTD (JP) | 2021-02-17 | — | — | EP | disclosed |
| EP-3750896-A1 | CHIRAL TETRADENTATE LIGAND, METHOD FOR PRODUCING SAME AND TRANSITION METAL COMPLEX OF SAID CHIRAL TETRADENTATE LIGAND | Takasago International Corporation (JP) | 2020-12-16 | — | — | EP | disclosed |
| EP-2943460-B1 | 6-CHLORO-3-(PHENYL-D5)-INDEN-1-ONE AND USE THEREOF | H LUNDBECK AS (DK) | 2020-02-12 | — | — | EP | disclosed |
| EP-2789600-A1 | Method for the preparation of ortho-acylated aromatic or heteroaromatic carboxylic acids | Saltigo GmbH (DE) | 2014-10-15 | — | — | EP | disclosed |
| WO-2013041106-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS 11CO FOR CARBONYLATION REACTIONS IN THE PREPARATION OF RADIOPHARMACEUTICALS FOR PET IMAGING | AARHUS UNIVERSITET (DK) | 2013-03-28 | — | — | WO | disclosed |
| WO-2012079583-A1 | SYSTEM PROVIDING CONTROLLED DELIVERY OF GASEOUS CO FOR CARBONYLATION REACTIONS | AARHUS UNIVERSITET (DK) | 2012-06-21 | — | — | WO | disclosed |
| US-7834215-B2 | Unsymmetrically substituted phospholane catalysts | EVONIK DEGUSSA GMBH (DE) | 2010-11-16 | — | — | US | disclosed |
| EP-1995248-A1 | Process for the production of amino alcohols by asymmetric hydrogenation | Evonik Degussa GmbH (DE) | 2008-11-26 | — | — | EP | disclosed |
| US-20080200695-A1 | Unsymmetrically Substituted Phospholane Catalysts | DEGUSSA GMBH (DE) | 2008-08-21 | — | — | US | disclosed |
| EP-1862446-A2 | Method for manufacturing enantiomer-enriched hydroxylamine derivatives | Evonik Degussa GmbH (DE) | 2007-12-05 | — | — | EP | disclosed |
| US-20070197799-A1 | Novel bisphosphane catalysts | DEGUSSA GMBH (DE) | 2007-08-23 | — | — | US | disclosed |
| EP-1805194-A1 | NOVEL BISPHOSPHANE CATALYSTS | Degussa GmbH (DE) | 2007-07-11 | — | — | EP | disclosed |
| WO-2006045388-A1 | NOVEL BISPHOSPHANE CATALYSTS | DEGUSSA AG (DE) | 2006-05-04 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240391878-A1 | METHOD FOR PREPARING TERT-BUTYL (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-1-CARBOXYLATE AND SALTS THEREOF AND ITS USE IN A METHOD FOR PREPARING (S)-4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE AND SALTS THEREOF | ADRA1A, AVPR1A, THRA | GPR3 2741/4885 |
| US-20070197799-A1 | Novel bisphosphane catalysts | BPGM, BCAT2, BCAT1 | GPR3 1746/4885 |
| US-20230219983-A1 | TETRADENTATE DIAMINODIPHOSPHINE LIGAND AND TRANSITION METAL COMPLEX, AND METHOD FOR MANUFACTURING SAME AND APPLICATION FOR SAME | ADH4, ADH5, PF4 | GPR3 4134/4885 |
| US-12012426-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | ADH4, ADH5, PF4 | GPR3 4134/4885 |
| US-11639362-B2 | Tetradentate diaminodiphosphine ligand and transition metal complex, and method for manufacturing same and application for same | ADH4, ADH5, PF4 | GPR3 4134/4885 |
| US-20080200695-A1 | Unsymmetrically Substituted Phospholane Catalysts | PGLS, PNKP, AGPS | GPR3 2726/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.